Aptamer-based fluorometric lateral flow assay for creatine kinase MB

Jing Zhang, Xuefei Lv, Wei Feng, Xiaoqiong Li*, Kunjie Li, Yulin Deng

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

45 Citations (Scopus)

Abstract

A group of aptamers possessing high specificity and affinity for creatine kinase MB (CKMB) was obtained by magnetic systematic evolution of ligands by exponential enrichment. Two aptamers (referred to as C.Apt.21 and C.Apt.30) were found to possess adequately low Kd values. They form a well suited pair for CKMB binding. By using fluorescent microspheres, an aptamer-based lateral flow assay was developed. It is portable, economical, and sensitive. The limit of detection for CKMB is as low as 0.63 ng·mL-1, and the assay works in the 0.005 - 2 μg·mL-1 CKMB concentration range. The method is specific for CKMB, and biomarkers for AMI (such as cardiac troponin I and myoglobin) and serum do not interfere. The strip is highly accurate as shown by analysis of spiked serum samples which gave recoveries ranging between 88 and 117%.

Original languageEnglish
Article number364
JournalMicrochimica Acta
Volume185
Issue number8
DOIs
Publication statusPublished - 1 Aug 2018

Keywords

  • Acute myocardial infarction
  • Aptamer
  • CKMB
  • Fluorescent microsphere
  • Lateral flow
  • Magnetic SELEX
  • Nanoparticles
  • Rapid detection
  • Sandwich
  • Test strip reader

Fingerprint

Dive into the research topics of 'Aptamer-based fluorometric lateral flow assay for creatine kinase MB'. Together they form a unique fingerprint.

Cite this